U.S. Company Credit Swaps Hold; Pfizer Sells $4 Billion in Bonds

A gauge of U.S. corporate credit risk was little changed as Pfizer Inc. sold $4 billion in bonds, its first debt offering since 2009.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.